PDL Practice Alert


pdl logo
Important changes to legislation regarding pseudoephedrine and naloxone On February 1, 2016, the scheduling on Naloxone changed from S4 to S3 for the treatment of opioid overdose. The two current suppliers of Naloxone have to this date not provided S3 packs so this means pharmacists supplying the product need to be aware of several factors

This content is restricted. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Northern flu season a sign for Australia: Terry White Group
Next Clinical tips: osteoarthritis